Purdue Pharma L.P.

Track this case

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 17, 2026

    What's Happening In Bankruptcy Court This Coming Week

    Purdue Pharma will undergo an omnibus hearing and get criminally sentenced, Office Properties Income Trust will seek plan confirmation and Spirit will vie for the all-clear to take a vote on its own plan.

  2. April 13, 2026

    Saks Nears Lease Settlement, ABI Says Bankruptcies Up

    Saks and mall owner Simon Property said they are closing in on an agreement resolving a dispute over leases, recycler Aleon Metals received plan approval and the American Bankruptcy Institute reported a first-quarter bump in bankruptcy filings.

  3. April 10, 2026

    Purdue Pharma To Be Sentenced For 2020 Guilty Plea

    More than five years after pleading guilty to conspiring to defraud the U.S. government, Purdue Pharma will be sentenced this month, according to a notice filed in the bankruptcy case of the OxyContin maker.

  4. April 09, 2026

    McKinsey Settles Liability For $125M In Purdue Ch. 11

    Consulting firm McKinsey & Co. has agreed to pay $125 million to former client Purdue Pharma LP to settle potential claims related to its work advising Purdue on the sale and marketing of opioids, tying up another loose end in the nearly seven-year-old Chapter 11 case.

  5. February 17, 2026

    Food52 Can Sell Assets, Saks Can Close 9 Stores

    A Delaware bankruptcy judge approved an agreement on the sale of some of e-commerce company Food52 Inc.'s assets to America's Test Kitchen, a Texas judge allowed Saks Global to start closing nine stores, and a New Jersey judge put the retail operator of outdoor clothing brand Eddie Bauer on track for a March auction.

  6. February 12, 2026

    Purdue Pharma Judge Declines To Stay Chapter 11 Plan

    A New York bankruptcy judge on Thursday denied motions by personal injury claimants in the Purdue Pharma LP case to stay the opioid maker's Chapter 11 plan, ruling that delaying the deal would be far too costly given the movants are not likely to succeed in an appeal.

  7. December 18, 2025

    Purdue Mediator Says Failure Was Not An Option, Part 2

    Former bankruptcy Judge Shelley C. Chapman mediated a $7.4 billion settlement in the Chapter 11 case of Purdue Pharma that received court approval last month. She spoke with Law360 about the pressure she faced to reach a deal and the 18-hour mediation sessions that came with renewed negotiations after the U.S. Supreme Court threw out a critical element of the agreement. She also discussed the role of nonmonetary relief for creditors, including the removal of the Sackler name from buildings and institutions.

  8. December 17, 2025

    Purdue Ch. 11 Mediator Says Settlement Took A Village, Part 1

    Former U.S. Bankruptcy Judge Shelley C. Chapman oversaw the most complex mediation she has seen to date as she guided settlement negotiations in the Chapter 11 case of OxyContin maker Purdue Pharma, and those efforts resulted in a $7.4 billion deal confirmed by a New York court last month.

  9. November 24, 2025

    Judge Explains OK For Purdue Ch. 11, Yellow Plan Confirmed

    A judge provided his reasons for approving Purdue's revised Chapter 11 plan, and Yellow Corp. and business internet service provider Everstream Solutions both obtained confirmation for their bankruptcy plans.

  10. November 18, 2025

    Purdue's $7.4B Ch. 11 Plan Jibes With New Release Paradigm

    A New York bankruptcy judge gave a bench ruling Tuesday explaining his decision to confirm Purdue's $7.4 billion Chapter 11 plan, which transforms the pharmaceutical giant into a public benefit company, ruling that liability releases fully comply with new restrictions imposed by the U.S. Supreme Court last year.